Immune dysfunction and neuroinflammation in autism spectrum disorder

Publications

Share / Export Citation / Email / Print / Text size:

Acta Neurobiologiae Experimentalis

Nencki Institute of Experimental Biology

Polish Neuroscience Society

Subject: Behavioral Sciences , Biomedical Sciences & Nutrition , Life Sciences , Medicine , Neurosciences

GET ALERTS

ISSN: 0065-1400
eISSN: 1689-0035

DESCRIPTION

150
Reader(s)
361
Visit(s)
0
Comment(s)
0
Share(s)

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue / page

Related articles

VOLUME 76 , ISSUE 4 (December 2016) > List of articles

Advertisement Immune dysfunction and neuroinflammation in autism spectrum disorder

Geir Bjørklund * / Khaled Saad / Salvatore Chirumbolo / Janet K. Kern / David A. Geier / Mark R. Geier / Mauricio A. Urbina

Keywords : autism, cytokines, innate immunity, neuroinflammation

Citation Information : Acta Neurobiologiae Experimentalis. Volume 76, Issue 4, Pages 257-268, DOI: https://doi.org/10.21307/ane-2017-025

License : (CC BY 4.0)

Received Date : 31-December-2015 / Accepted: 06-September-2016 / Published Online: 26-July-2017

ARTICLE

ABSTRACT

Autism spectrum disorder (ASD) is a complex heterogeneous neurodevelopmental disorder with a complex pathogenesis. Many studies over the last four decades have recognized altered immune responses among individuals diagnosed with ASD. The purpose of this critical and comprehensive review is to examine the hypothesis that immune dysfunction is frequently present in those with ASD. It was found that often individuals diagnosed with ASD have alterations in immune cells such as T cells, B cells, monocytes, natural killer cells, and dendritic cells. Also, many individuals diagnosed with ASD have alterations in immunoglobulins and increased autoantibodies. Finally, a significant portion of individuals diagnosed with ASD have elevated peripheral cytokines and chemokines and associated neuroinflammation. In conclusion, immune dysregulation and inflammation are important components in the diagnosis and treatment of ASD.

Content not available PDF Share

FIGURES & TABLES

REFERENCES

  1. Ahmad SF, Zoheir KM, Ansari MA, Nadeem A, Bakheet SA, Al-Ayadhi LY, Alzahrani MZ, Al-Shabanah OA, Al-Harbi MM, Attia SM (2016) Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism. Mol Neurobiol. doi: 10.1007/s12035-016-9977-0.
    [CROSSREF]
  2. Akintunde ME, Rose M, Krakowiak P, Heuer L, Ashwood P, Hansen R, Hertz-Picciotto I, Van de Water J (2015) Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma. J Neuroimmunol 286: 33–41.
  3. Al-Ayadhi LY, Mostafa GA (2012) Elevated serum levels of interleukin-17A in children with autism. J Neuroinflammation 9: 158.
  4. Al-Ayadhi LY, Mostafa GA (2013) Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children. J Neuroinflammation 10: 72. APA – American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association, Washington, USA.
  5. Ashwood P, Anthony A, Torrente F, Wakefield AJ (2004) Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 24: 664–673.
  6. Ashwood P, Corbett BA, Kantor A, Schulman H, Van de Water J, Amaral DG (2011a) In search of cellular immunophenotypes in the blood of children with autism. PLoS One 6: e19299.
  7. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J (2011b) Altered T cell responses in children with autism. Brain Behav Immun 25: 840–849.
  8. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J (2011c) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25: 40–45.
  9. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J (2011d) Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol 232: 196–199.
  10. Ashwood P, Wills S, Van de Water J (2006) The immune response in autism: a new frontier for autism research. J Leukoc Biol 80: 1–15.
  11. Bailey AR, Hou H, Obregon DF, Tian J, Zhu Y, Zou Q, Nikolic WV, Bengtson M, Mori T, Murphy T, Tan J (2012) Aberrant T-lymphocyte development and function in mice overexpressing human soluble amyloid precursor protein-α: implications for autism. FASEB J 26: 1040–1051.
  12. Bakroon A, Lakshminarayanan V (2016) Visual function in autism spectrum disorders: a critical review. Clin Exp Optom. doi: 10.1111/cxo.12383.
  13. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767–811.
  14. Baron-Cohen S, Wheelwright S (2004) The empathy quotient: an investigation of adults with Asperger syndrome or high functioning autism, and normal sex differences. J Autism Dev Disord 34: 163–175.
  15. Bayram AK, Kardas F, Demirci EO, Gokahmetoglu S, Ozmen S, Canpolat M, Oztop DB, Kumandas S, Gumus H, Per H (2016) Lack of serum antineuronal antibodies in children with autism. Bratisl Lek Listy 117: 77–79.
  16. Berdowska A, Zwirska-Korczala K (2001) Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 26: 319–329.
  17. Bjørklund G (2013) The role of zinc and copper in autism spectrum disorders. Acta Neurobiol Exp (Wars) 73: 225–236.
  18. Blanco-Suárez E, Caldwell AL, Allen NJ (2016) Role of astrocyte-synapse interactions in CNS disorders. J Physiol. doi: 10.1113/JP270988.
  19. Breece E, Paciotti B, Nordahl CW, Ozonoff S, Van de Water JA, Rogers SJ, Amaral D, Ashwood P (2013) Myeloid dendritic cells frequencies are increased in children with autism spectrum disorder and associated with amygdala volume and repetitive behaviors. Brain Behav Immun 31: 69–75.
  20. Bressler JP, Gillin PK, O’Driscoll C, Kiihl S, Solomon M, Zimmerman AW (2012) Maternal antibody reactivity to lymphocytes of offspring with autism. Pediatr Neurol 47: 337–340.
  21. Brown AS, Surcel HM, Hinkka-Yli-Salomäki S, Cheslack-Postava K, Bao Y, Sourander A (2015) Maternal thyroid autoantibody and elevated risk of autism in a national birth cohort. Prog Neuropsychopharmacol Biol Psychiatry 57: 86–92.
  22. Businaro R, Corsi M, Azzara G, Di Raimo T, Laviola G, Romano E, Ricci L, Maccarrone M, Aronica E, Fuso A, Ricci S (2016) Interleukin-18 modulation in autism spectrum disorders. J Neuroinflammation 13: 2.
  23. Cabanlit M, Wills S, Goines P, Ashwood P, Van de Water J (2007) Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann N Y Acad Sci 1107: 92–103.
  24. Cannell JJ, Grant WB (2013) What is the role of vitamin D in autism?. Dermatoendocrinol 5: 199–204.
  25. Careaga M, Rogers S, Hansen RL, Amaral DG, Van de Water J, Ashwood P (2015) Immune endophenotypes in children with autism spectrumdisorder. Biol Psychiatry. doi: 10.1016/j.biopsych.2015.08.036.
  26. Chirumbolo S (2015) The role of vitamin D towards immune tolerance in white adipose tissue (WAT). Endocr Metab Immune Disord Drug Targets 15: 277–287.
  27. Choi GB, Yim YS, Wong H, Kim S, Kim H, Kim SV, Hoeffer CA, Littman DR, Huh JR (2016) The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351: 933–939.
  28. Codagnone MG, Podestá MF, Uccelli NA, Reinés A (2015) Differential local connectivity and neuroinflammation profiles in the medial prefrontal cortex and hippocampus in the valproic acid rat model of autism. Dev Neurosci 37(3): 215–231.
  29. Connolly AM, Chez M, Streif EM, Keeling RM, Golumbek PT, Kwon JM, Riviello JJ, Robinson RG, Neuman RJ, Deuel RM (2006) Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry 59: 354–363.
  30. Crăciun EC, Bjørklund G, Tinkov AA, Urbina MA, Skalny AV, Rad F, Dronca E (2016) Evaluation of whole blood zinc and copper levels in children with autism spectrum disorder. Metab Brain Dis 31: 887–890.
  31. Croen LA, Braunschweig D, Haapanen L, Yoshida CK, Fireman B, Grether JK, Kharrazi M, Hansen RL, Ashwood P, Van de Water J (2008) Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol Psychiatry 64: 583–588.
  32. Croonenberghs J, Bosmans E, Deboutte D, Kenis G, Maes M (2002a) Activation of the inflammatory response system in autism. Neuropsychobiology 45: 1–6.
  33. Croonenberghs J, Wauters A, Devreese K, Verkerk R, Scharpe S, Bosmans E, Egyed B, Deboutte D, Maes M (2002b) Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychol Med 32: 1457–1463.
  34. De Jong M, Punt M, De Groot E, Minderaa RB, Hadders-Algra M (2011) Minor neurological dysfunction in children with autism spectrum disorder. Dev Med Child Neurol 53: 641–646.
  35. Denny DR, Frei BW, Gaffney GR (1996) Lymphocyte subsets and interleukin-2 receptors in autistic children. J Autism Dev Disord 26: 87–97.
  36. Elamin NE, Al-Ayadhi LY (2014) Brain autoantibodies in autism spectrum disorder. Biomark Med 8: 345–352.
  37. Endreffy I, Bjørklund G, Dicső F, Urbina MA, Endreffy E (2016) Acid glycosaminoglycan (aGAG) excretion is increased in children with autism spectrum disorder, and it can be controlled by diet. Metab Brain Dis 31: 273–278.
  38. Enstrom AM, Lit L, Onore CE, Gregg JP, Hansen RL, Pessah IN, Hertz-Picciotto I, Van de Water JA, Sharp FR, Ashwood P (2009) Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun 23: 124–133.
  39. Enstrom AM, Onore CE, Van de Water JA, Ashwood P (2010) Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 24: 64–71.
  40. Esparham AE, Smith T, Belmont JM, Haden M, Wagner LE, Evans RG, Drisko JA (2015) Nutritional and metabolic biomarkers in autism spectrum disorders: an exploratory study. Integr Med (Encinitas) 14: 40–53.
  41. Estes ML, McAllister AK (2015) Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci 16: 469–486.
  42. Estes ML, McAllister AK (2016) IMMUNOLOGY. Maternal TH17 cells take a toll on baby’s brain. Science 351: 919–920.
  43. Faber S, Zinn GM, Kern JC 2nd, Kingston HM (2009) The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers 14: 171–180.
  44. Fujiwara T, Morisaki N, Honda Y, Sampei M, Tani Y (2016) Chemicals, nutrition, and autism spectrum disorder: a mini-review. Front Neurosci 10: 174.
  45. Furlano RI, Anthony A, Day R, Brown A, McGarvey L, Thomson MA, Davies SE, Berelowitz M, Forbes A, Wakefield AJ, Walker-Smith JA, Murch SH (2001) Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr 138: 366–372.
  46. Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, Mirnics K, Persico AM (2008) Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 30: 303–311.
  47. Goines PE, Ashwood P (2013) Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol Teratol 36: 67–81.
  48. Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J, Hansen R, Kharrazi M, Ashwood P, Van de Water J (2011) Increased midgestational IFN-γ, IL 4 and IL-5 in women bearing a child with autism: A case-control study. Mol Autism 2: 13.
  49. Gottfried C, Bambini-Junior V, Francis F, Riesgo R, Savino W (2015) The impact of neuroimmune alterations in autism spectrum disorder. Front Psychiatry 6: 121.
  50. Grigorenko EL, Han SS, Yrigollen CM, Leng L, Mizue Y, Anderson GM, Mulder EJ, de Bildt A, Minderaa RB, Volkmar FR, Chang JT, Bucala R (2008) Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics 122: e438–e445.
  51. Guerini FR, Bolognesi E, Chiappedi M, Manca S, Ghezzo A, Agliardi C, Zanette M, Littera R, Carcassi C, Sotgiu S, Clerici M (2014) Activating KIR molecules and their cognate ligands prevail in children with a diagnosis of ASD and in their mothers. Brain Behav Immun 36: 54–60.
  52. Gupta S, Aggarwal S, Heads C (1996) Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord 26: 439–452.
  53. Gupta S, Aggarwal S, Rashanravan B, Lee T (1998) Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 85: 106–109.
  54. Heuer L, Ashwood P, Schauer J, Goines P, Krakowiak P, Hertz-Picciotto I, Hansen R, Croen LA, Pessah IN, Van de Water J (2008) Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res 1: 275–283.
  55. Heuer LS, Rose M, Ashwood P, Van de Water J (2012) Decreased levels of total immunoglobulin in children with autism are not a result of B cell dysfunction. J Neuroimmunol 251: 94–102.
  56. Hirahara K, Nakayama T (2016) CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm. Int Immunol 28: 163–171.
  57. Howlin P (2003) Outcome in high-functioning adults with autism with and without early language delays: implications for the differentiation between autism and Asperger syndrome. J Autism Dev Disord 33: 3–13.
  58. Hsiao EY (2013) Immune dysregulation in autism spectrum disorder. Int Rev Neurobiol 113: 269–302.
  59. Hsiao EY, McBride SW, Chow J, Mazmanian SK, Patterson PH (2012) Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc Natl Acad Sci U S A 109: 12776–12781.
  60. Jašarević E, Howerton CL, Howard CD, Bale TL (2015) Alterations in the vaginal microbiome by maternal stress are associated with metabolic reprogramming of the offspring gut and brain. Endocrinology 156: 3265–3276.
  61. Jyonouchi H, Geng L, Davidow AL (2014) Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: an inflammatory subtype? J Neuroinflammation 11: 187.
  62. Jyonouchi H, Geng L, Ruby A, Zimmerman-Bier B (2005) Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 51: 77–85.
  63. Jyonouchi H, Geng L, Streck DL, Toruner GA (2012) Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study. J Neuroinflammation 9: 4.
  64. Kajizuka M, Miyachi T, Matsuzaki H, Iwata K, Shinmura C, Suzuki K, Suda S, Tsuchiya KJ, Matsumoto K, Iwata Y, Nakamura K, Tsujii M, Sugiyama T, Takei N, Mori N (2010) Serum levels of platelet-derived growth factor BB homodimers are increased in male children with autism. Prog Neuropsychopharmacol Biol Psychiatry 34: 154–158.
  65. Kern JK, Geier DA, Sykes LK, Homme KG, Geier MR (2014) Medical conditions in autism and events associated with initial onset of autism. OA Autism 2(1): 9.
  66. Khaled EM, Meguid NA, Bjørklund G, Gouda A, Bahary MH, Hashish A, Sallam NM, Chirumbolo S, El-Bana MA (2016) Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder. Metab Brain Dis. doi: 10.1007/ s11011-016-9870-6.
  67. Kim SY, Porter BE, Friedman A, Kaufer D (2016) A potential role for glia-derived extracellular matrix remodeling in postinjury epilepsy. J Neurosci Res 94: 794–803.
  68. Kinoshita M, Takeda K (2014) Microbial and dietary factors modulating intestinal regulatory T cell homeostasis. FEBS Lett 588: 4182–4187.
  69. Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Hansen RL, Hertz-Picciotto I, Van de Water J (2015) Neonatal cytokine profiles associated with autism spectrum disorder. Biol Psychiatry. doi: 10.1016/j.biopsych.2015.08.007.
  70. Lau NM, Green PH, Taylor AK, Hellberg D, Ajamian M, Tan CZ, Kosofsky BE, Higgins JJ, Rajadhyaksha AM, Alaedini A (2013) Markers of celiac disease and gluten sensitivity in children with autism. PLoS One 8: e66155.
  71. Li Q, Zhou JM (2016) The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder. Neuroscience 324: 131–139.
  72. Li SO, Wang JL, Bjørklund G, Zhao WN, Yin CH (2014) Serum copper and zinc levels in individuals with autism spectrum disorders. Neuroreport 25: 1216–1220.
  73. Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T, Malik M (2009) Elevated immune response in the brain of autistic patients. J Neuroimmunol 207: 111–116.
  74. Linkovski O, Katzin N, Salti M (2016) Mirror neurons and mirror-touch synesthesia. Neuroscientist. doi: 10.73858416652079.
  75. López-Cacho JM, Gallardo S, Posada M, Aguerri M, Calzada D, Mayayo T, Lahoz C, Cárdaba B (2016) Characterization of immune cell phenotypes in adults with autism spectrum disorders. J Investig Med. doi: 10.1136/ jim-2016-000070.
  76. Luna RA, Savidge TC, Williams KC (2016) The brain-gut-microbiome axis: What role does it play in autism spectrum disorder? Curr Dev Disord Rep 3: 75–81.
  77. Macedoni-Lukšič M, Gosar D, Bjørklund G, Oražem J, Kodrič J, Lešnik-Musek P, Zupančič M, France-Štiglic A, Sešek-Briški A, Neubauer D, Osredkar J (2015) Levels of metals in the blood and specific porphyrins in the urine in children with autism spectrum disorders. Biol Trace Elem Res 163: 2–10.
  78. Magid-Bernstein J, Mahajan K, Lincoln J, Ming X, Rohowsky-Kochan C (2015) Case report: cytokine and CD4+ T-cell profiles of monozygotic twins with autism and divergent comorbidities and drug treatment. J Child Neurol 30: 386–390.
  79. Malavasi F, Deaglio S, Ferrero E, Funaro A, Sancho J, Ausiello CM, Ortolan E, Vaisitti T, Zubiaur M, Fedele G, Aydin S, Tibaldi EV, Durelli I, Lusso R, Cozno F, Horenstein AL (2006) CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity. Mol Med 12: 334–341.
  80. Manzardo AM, Henkhaus R, Dhillon S, Butler MG (2012) Plasma cytokine levels in children with autistic disorder and unrelated siblings. Int J Dev Neurosci 30: 121–127.
  81. Masi A, Quintana DS, Glozier N, Lloyd AR, Hickie IB, Guastella AJ (2015) Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry 20: 440–446. Mead J, Ashwood P (2015) Evidence supporting an altered immune response in ASD. Immunol Lett 163: 49–55.
  82. Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Courtney P, Altaye M, Wills-Karp M (2006) Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 172: 198–205.
  83. Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683–765.
  84. Morgan JT, Chana G, Pardo CA, Achim C, Semendeferi K, Buckwalter J, Courchesne E, Everall IP (2010) Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 68: 368–376.
  85. Mostafa GA, Al-Ayadhi LY (2012) Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: relation to autoimmunity. J Neuroinflammation 9: 201.
  86. Mostafa GA, Al-Ayadhi LY (2015) The possible association between elevated levels of blood mercury and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children. J Clin Cell Immunol 6: 310. doi: 10.4172/2155-9899.1000310.
  87. Mostafa GA, Al Shehab A, Fouad NR (2010) Frequency of CD4+CD25high regulatory T cells in the peripheral blood of Egyptian children with autism. J Child Neurol 25: 328–335.
  88. Mostafa GA, Bjørklund G, Urbina MA, Al-Ayadhi LY (2016a) The levels of blood mercury and inflammatory-related neuropeptides in the serum are correlated in children with autism spectrum disorder. Metab Brain Dis 31(3): 593–599.
  89. Mostafa GA, Bjørklund G, Urbina MA, Al-Ayadhi LY (2016b) The positive association between elevated blood lead levels and brainspecific autoantibodies in autistic children from low lead-polluted areas. Metab Brain Dis 31(3): 1047–1054.
  90. Mostafa GA, El-Sherif DF, Al-Ayadhi LY (2014) Systemic auto-antibodies in children with autism. J Neuroimmunol 272: 94–98.
  91. Mostafa GA, El-Khashab HY, Al-Ayadhi LY (2015) A possible association between elevated serum levels of brain specific auto-antibodies and reduced plasma levels of docosahexaenoic acid in autistic children. J Neuroimmunol 280: 16–20.
  92. Mostafa GA, Refai TMK (2007) Antineuronal antibodies in autistic children: relation to blood mercury. Egypt J Pediatr Allergy Immunol 5: 21–30.
  93. Nakagawa Y, Chiba K (2016) Involvement of neuroinflammation during brain development in social cognitive deficits in autism spectrum disorder and schizophrenia. J Pharmacol Exp Ther 358(3): 504–515.
  94. Nguyen LS, Lepleux M, Makhlouf M, Martin C, Fregeac J, Siquier-Pernet K, Philippe A, Feron F, Gepner B, Rougeulle C, Humeau Y, Colleaux L (2016) Profiling olfactory stem cells from living patients identifies miRNAs relevant for autism pathophysiology. Mol Autism 7: 1.
  95. Noriega DB, Savelkoul HF (2014) Immune dysregulation in autism spectrum disorder. Eur J Pediatr 173: 33–43.
  96. Onore C, Careaga M, Ashwood P (2012) The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26: 383–392.
  97. Pecorelli A, Cervellati F, Belmonte G, Montagner G, Waldon P, Hayek J, Gambari R, Valacchi G (2016) Cytokines profile and peripheral blood mononuclear cellsmorphology in Rett and autistic patients. Cytokine 77: 180–188.
  98. Piras IS, Haapanen L, Napolioni V, Sacco R, Van de Water J, Persico AM (2014) Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with autism spectrum disorder. Brain Behav Immun 38: 91–99.
  99. Poletaev AB, Poletaeva AA, Pukhalenko AI, Zamaleeva RS, Cherepanova NA, Frizin DV (2014) Adaptive maternal immune deviations as a ground for autism spectrum disorders development in children. Folia Med (Plovdiv) 56: 73–80.
  100. Ricci S, Businaro R, Ippoliti F, Lo Vasco VR, Massoni F, Onofri E, Troili GM, Pontecorvi V, Morelli M, Rapp Ricciardi M, Archer T (2013) Altered cytokine and BDNF levels in autism spectrum disorder. Neurotox Res 24: 491–501.
  101. Rodriguez JI, Kern JK (2011) Evidence of microglial activation in autism and its possible role in brain underconnectivity. Neuron Glia Biol 7: 205–213.
  102. Rosenspire A, Yoo W, Menard S, Torres AR (2011) Autism spectrum disorders are associated with an elevated autoantibody response to tissue transglutaminase-2. Autism Res 4: 242–249.
  103. Ross HE, Guo Y, Coleman K, Ousley O, Miller AH (2013) Association of IL-12p70 and IL-6:IL-10 ratio with autism-related behaviors in 22q11.2 deletion syndrome: a preliminary report. Brain Behav Immun 31: 76–81.
  104. Rossignol DA (2007) Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism. Med Hypotheses 68: 1208–1227.
  105. Ruggeri B, Sarkans U, Schumann G, Persico AM (2014) Biomarkers in autism spectrum disorder: the old and the new. Psychopharmacology (Berl) 231: 1201–1216.
  106. Saad K, Abdel-Rahman AA, Elserogy YM, Al-Atram AA, Cannell JJ, Bjørklund G, Abdel-Reheim MK, Othman HA, El-Houfey AA, Abd El-Aziz NH, Abd El Baseer KA, Ahmed AE, Ali AM (2015) Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children. Nutr Neurosci. doi: 10.1179/14 76830515Y.0000000019.
  107. Saffin JM, Tohid H (2016) Walk like me, talk like me. The connection between mirror neurons and autism spectrum disorder. Neurosciences (Riyadh) 21: 108–119.
  108. Sakamoto A, Moriuchi H, Matsuzaki J, Motoyama K, Moriuchi M (2015) Retrospective diagnosis of congenital cytomegalovirus infection in children with autism spectrum disorder but no other major neurologic deficit. Brain Dev 37: 200–205.
  109. Saresella M, Marventano I, Guerini FR, Mancuso R, Ceresa L, Zanzottera M, Rusconi B, Maggioni E, Tinelli C, Clerici M (2009) An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biol Psychiatry 66: 978–984.
  110. Schulte-Rüther M, Otte E, Adigüzel K, Firk C, Herpertz-Dahlmann B, Koch I, Konrad K (2016) Intact mirror mechanisms for automatic facial emotions in children and adolescents with autism spectrum disorder. Autism Res. doi: 10.1002/aur.1654.
  111. Scifo R, Cioni M, Nicolosi A, Batticane N, Tirolo C, Testa N, Quattropani MC, Morale MC, Gallo F, Marchetti B (1996) Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone. Ann Ist Super Sanita 32: 351–359.
  112. Sharpe MA, Gist TL, Baskin DS (2013a) Alterations in sensitivity to estrogen, dihydrotestosterone, and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twins/siblings. J Toxicol: 159810. doi: 10.1155/2013/159810.
  113. Sharpe MA, Gist TL, Baskin DS (2013b) B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal. J Toxicol 2013: 801517. doi: 10.1155/2013/801517.
  114. Singh VK (1996) Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J Neuroimmunol 66: 143–145.
  115. Siniscalco D (2015) Commentary: The impact of neuroimmune alterations in autism spectrum disorder. Front Psychiatry 6: 145.
  116. Siniscalco D, Bradstreet JJ, Cirillo A, Antonucci N (2014) The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages. J Neuroinflammation 11: 78.
  117. Siniscalco D, Mijatovic T, Bosmans E, Cirillo A, Kruzliak P, Lombardi VC, DE Meirleir K, Antonucci N (2016) Decreased numbers of CD57+CD3- cells
    identify potential innate immune differences in patients with autism spectrum disorder. In Vivo 30: 83–89.
  118. Stamova BS, Tian Y, Nordahl CW, Shen MD, Rogers S, Amaral DG, Sharp FR (2013) Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders. Mol Autism 4: 30. doi: 10.1186/2040-2392-4-30.
  119. Steinman RM (2007) Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune system. Nat Med 13: 1155–1159.
  120. Stubbs G (1995) Interferonemia and autism. J Autism Dev Disord 25: 71–73.
  121. Sweeten TL, Posey DJ, McDougle CJ (2003) High blood monocyte counts and neopterin levels in children with autistic disorder. Am J Psychiatry 160: 1691–1693.
  122. Theoharides TC (2013) Is a subtype of autism an allergy of the brain? Clin Ther 35(5): 584–591.
  123. Theoharides TC, Angelidou A, Alysandratos KD, Zhang B, Asadi S, Francis K, Toniato E, Kalogeromitros D (2012) Mast cell activation and autism. Biochim Biophys Acta 1822: 34–41.
  124. Theoharides TC, Tsilioni I, Patel AB, Doyle R (2016) Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders. Transl Psychiatry 6: e844. doi: 10.1038/tp.2016.77.
  125. Torrente F, Ashwood P, Day R, Machado N, Furlano RI, Anthony A, Davies SE, Wakefield AJ, Thomson MA, Walker-Smith JA, Murch SH (2002) Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 7: 375–382.
  126. Tsilioni I, Dodman N, Petra AI, Taliou A, Francis K, Moon-Fanelli A, Shuster L, Theoharides TC (2014) Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders and tail-chasing Bull Terriers with a phenotype similar to autism. Transl Psychiatry 4: e466. doi: 10.1038/tp.2014.106.
  127. Ueno H, Klechevsky E, Morita R, Aspord C, Cao T, Matsui T (2007) Dendritic cell subsets in health and disease. Immunol Rev 219: 118–142.
  128. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57: 67–81.
  129. Vojdani A, Mumper E, Granpeesheh D, Mielke L, Traver D, Bock K, Hirani K, Neubrander J, Woeller KN, O’Hara N, Usman A, Schneider C, Hebroni F, Berookhim J, McCandless J (2008) Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J. Neuroimmunol 205: 148–154.
  130. Wang TT, DU L, Shan L, Jia FY (2014) Research advances in immunological dysfunction in children with autism spectrum disorders (in Chinese). Zhongguo Dang Dai Er Ke Za Zhi 16: 1289–1293.
  131. Warren RP, Yonk LJ, Burger RA, Cole P, Odell JD, Warren WL, White E, Singh VK (1990) Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. Immunol Invest 19: 245–251.
  132. Wasilewska J, Kaczmarski M, Stasiak-Barmuta A, Tobolczyk J, Kowalewska E (2012) Low serum IgA and increased expression of CD23 on G. Bjørklund et al.
  133. B lymphocytes in peripheral blood in children with regressive autism aged 3–6 years old. Arch Med Sci 8: 324–331.
  134. Wei H, Alberts I, Li X (2013) Brain IL-6 and autism. Neuroscience 252: 320–325.
  135. Wills S, Cabanlit M, Bennett J, Ashwood P, Amaral D, Van de Water J (2007) Autoantibodies in autism spectrum disorders. Ann N Y Acad Sci 1107: 79–91.
  136. Wu S, Ding Y, Wu F, Li R, Xie G, Hou J, Mao P (2015) Family history of autoimmune diseases is associated with an increased risk of autism in children: A systematic review and meta-analysis. Neurosci Biobehav Rev 55: 322–332.
  137. Yang J, Hofmann J (2015) Action observation and imitation in autism spectrum disorders: an ALE meta-analysis of fMRI studies. Brain Imaging Behav. doi: 10.1007/s11682-015-9456-7.
  138. Yokoyama S, Al Mahmuda N, Munesue T, Hayashi K, Yagi K, Yamagishi M, Higashida H (2015) Association study between the CD157/BST1 gene
    and autism spectrum disorders in a Japanese population. Brain Sci 5: 188–200.
  139. Yonk LJ, Warren RP, Burger RA, Cole P, Odell JD, Warren WL, White E, Singh VK (1990) CD4+ helper T cell depression in autism. Immunol Lett 25: 341–345.
  140. Young AM, Chakrabarti B, Roberts D, Lai MC, Suckling J, Baron-Cohen S (2016) From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition. Mol Autism 7: 9.
  141. Xu N, Li X, Zhong Y (2015) Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders. Mediators Inflamm 2015: 531518.
  142. Zantomio D, Chana G, Laskaris L, Testa R, Everall I, Pantelis C, Skafidas E (2015) Convergent evidence for mGluR5 in synaptic and neuroinflammatory pathways implicated in ASD. Neurosci Biobehav Rev 52: 172–177.
  143. Zatkova M, Bakos J, Hodosy J, Ostatnikova D (2016) Synapse alterations in autism: Review of animal model findings. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 160(2): 201–210.
  144. Zerbo O, Traglia M, Yoshida C, Heuer LS, Ashwood P, Delorenze GN, Hansen RL, Kharrazi M, Van de Water J, Yolken RH, Weiss LA, Croen LA (2016) Maternal mid-pregnancy C-reactive protein and risk of autism spectrum disorders: the early markers for autism study. Transl Psychiatry 6: e783.
  145. Zerbo O, Yoshida C, Grether JK, Van de Water J, Ashwood P, Delorenze GN, Hansen RL, Kharrazi M, Croen LA (2014) Neonatal cytokines and chemokines and risk of autism spectrum disorder: the Early Markers for Autism (EMA) study: a case-control study. J Neuroinflammation 11: 113.
  146. Zhao HX, Yin SS, Fan JG (2015) High plasma neopterin levels in Chinese children with autism spectrum disorders. Int J Dev Neurosci 41: 92–97.
  147. Zikopoulos B, Barbas H (2010) Changes in prefrontal axons may disrupt the network in autism. J Neurosci 30: 14595–14609.
  148. Zikopoulos B, Barbas H (2013) Altered neural connectivity in excitatory and inhibitory cortical circuits in autism. Front Hum Neurosci 7: 609. doi: 10.3389/fnhum.2013.00609.
  149. Zimmerman AW, Connors SL, Matteson KJ, Lee LC, Singer HS, Castaneda JA, Pearce DA (2007) Maternal antibrain antibodies in autism. Brain Behav Immun 21: 351–357.

EXTRA FILES

COMMENTS